Centre de Référence des Maladies Autoinflammatoires et des Amyloses
- World rank, all time
- #31,257 of 42,892
- Rank in France
- #1,758 of 2,321
- Research works
- 120 ▲ 129% vs 2013–17
- Citations
- 1.6k 13.2 per fractional work
- Top-10% rate
- 15.8% record average 16.5%
- Open access
- 38% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.8×. Every wedge is a field page.
- Immunology and Microbiology 7.8×
- Medicine 3.4×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Nursing 1.6×
- Health Professions 1.1×
- Neuroscience 0.8×
- Arts and Humanities 0.4×
- Environmental Science 0.3×
- Earth and Planetary Sciences 0.2×
- Social Sciences 0.2×
- Engineering 0.1×
- Psychology 0.1×
- Chemistry 0.1×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.0×
- Economics, Econometrics and Finance 0.0×
- Mathematics 0.0×
Which keywords describe research at Centre de Référence des Maladies Autoinflammatoires et des Amyloses?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Immune Response, Autoantibodies, Juvenile Idiopathic Arthritis, Immunosuppressive Therapy, Inflammasome, NLRP3 and Epidemiology.
- Biological Therapy
- Systemic Lupus Erythematosus
- Cardiac Manifestations
- TGF-ß Signaling
- Inflammatory Diseases
- Cardiovascular Risk
- Fibrosis
- Genetic Mutations
- Uveitis
- Management
- Macrophage Activation Syndrome
- ANCA-associated
- Somatic Mutations
- Clinical Features
- Treatment
- NLRP3
- Immunosuppressive Therapy
- Autoantibodies
- Epidemiology
- Inflammation
- Immune Response
- Juvenile Idiopathic Arthritis
- Inflammasome
- Diagnosis
- Rituximab
- Relapsing Polychondritis
- VEXAS Syndrome
- Hemophagocytic Lymphohistiocytosis
- Vasculitides
- Behçet's Disease
- Endothelial Dysfunction
- Cancer
- Thrombosis
- Toll-like Receptors
- Pathogenesis
- Antiphospholipid Syndrome
- Interferon-inducible Genes
- Treatment Guidelines
- Rheumatoid Arthritis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 39 words, with their numbers
- Inflammation7▲ 7.4×32 topics
- Epidemiology5▲ 2.6×31 topics
- Immune Response4▲ 17×11 topics
- Autoantibodies4▲ 35×8 topics
- Juvenile Idiopathic Arthritis4▲ 157×2 topics
- Immunosuppressive Therapy4▲ 41×7 topics
- Inflammasome4▲ 184×1 topic
- NLRP34▲ 184×1 topic
- Diagnosis3▲ 6.8×14 topics
- Treatment3▲ 5.2×12 topics
- Rituximab2▲ 34×4 topics
- Clinical Features2▲ 136×3 topics
- Relapsing Polychondritis2▲ 466×1 topic
- Somatic Mutations2▲ 58×2 topics
- VEXAS Syndrome2▲ 466×1 topic
- ANCA-associated2▲ 178×1 topic
- Hemophagocytic Lymphohistiocytosis2▲ 185×1 topic
- Macrophage Activation Syndrome2▲ 185×1 topic
- Vasculitides2▲ 178×1 topic
- Management2▲ 4.9×10 topics
- Behçet's Disease2▲ 133×1 topic
- Uveitis2▲ 133×1 topic
- Endothelial Dysfunction2▲ 15×4 topics
- Genetic Mutations2▲ 7.4×7 topics
- Cancer1▲ 2.2×12 topics
- Fibrosis1▲ 16×3 topics
- Thrombosis1▲ 11×7 topics
- Cardiovascular Risk1▲ 8.6×3 topics
- Toll-like Receptors1▲ 25×2 topics
- Inflammatory Diseases1▲ 14×4 topics
- Pathogenesis1▲ 5.0×8 topics
- TGF-ß Signaling1▲ 40×4 topics
- Antiphospholipid Syndrome1▲ 49×1 topic
- Cardiac Manifestations1▲ 63×2 topics
- Interferon-inducible Genes1▲ 49×1 topic
- Systemic Lupus Erythematosus1▲ 45×2 topics
- Treatment Guidelines1▲ 11×3 topics
- Biological Therapy1▲ 40×2 topics
- Rheumatoid Arthritis1▲ 22×2 topics
Which research topics does Centre de Référence des Maladies Autoinflammatoires et des Amyloses publish most on?
By volume in 2022–2025: Inflammasome and immune disorders, Otitis Media and Relapsing Polychondritis, Vasculitis and related conditions and Autoimmune and Inflammatory Disorders Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Inflammasome and immune disorders Molecular Biology 4 works
- 2 Otitis Media and Relapsing Polychondritis Rheumatology 2 works
- 3 Vasculitis and related conditions Pulmonary and Respiratory Medicine 2 works
- 4 Autoimmune and Inflammatory Disorders Research Hematology 2 works
- 5 Ocular Diseases and Behçet’s Syndrome Ophthalmology 2 works
- 6 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 7 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
- 8 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
- 9 Immunodeficiency and Autoimmune Disorders Immunology 1 works
- 10 IL-33, ST2, and ILC Pathways Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Centre de Référence des Maladies Autoinflammatoires et des Amyloses's research output changed?
Output in 2018–2022 was 129% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.